19-5587948-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014649.3(SAFB2):c.2558G>A(p.Arg853Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014649.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SAFB2 | NM_014649.3 | c.2558G>A | p.Arg853Gln | missense_variant | 19/21 | ENST00000252542.9 | |
SAFB2 | XM_011528449.4 | c.2558G>A | p.Arg853Gln | missense_variant | 19/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SAFB2 | ENST00000252542.9 | c.2558G>A | p.Arg853Gln | missense_variant | 19/21 | 1 | NM_014649.3 | P1 | |
SAFB2 | ENST00000587802.5 | n.146G>A | non_coding_transcript_exon_variant | 2/4 | 3 | ||||
SAFB2 | ENST00000589925.1 | n.426G>A | non_coding_transcript_exon_variant | 5/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000814 AC: 2AN: 245786Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134048
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460618Hom.: 0 Cov.: 33 AF XY: 0.00000826 AC XY: 6AN XY: 726596
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2023 | The c.2558G>A (p.R853Q) alteration is located in exon 19 (coding exon 19) of the SAFB2 gene. This alteration results from a G to A substitution at nucleotide position 2558, causing the arginine (R) at amino acid position 853 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at